A crowded field of Democratic candidates for California governor has split the vote, creating an opening for Republicans. California's "jungle primary" system allows the top two finishers, regardless ...

Denali Therapeutics’ tividenofusp alfa (Avlayah) has secured accelerated approval for Hunter syndrome, a rare metabolic disease. The first-in-modality biologic — an enzyme fused to a blood–brain ...

Dietitians say you shouldn't take these vitamins in the morning Full list of US airports with no TSA—and no long lines Prosecutor told judge no evidence existed to criminally pursue Powell over costly ...

Please provide your email address to receive an email when new articles are posted on . Hand-foot syndrome is a painful adverse event from chemotherapy, particularly capecitabine. Data show an ...

For individuals living with fragile X syndrome — a common genetic disorder that is correlated with autism, causes intellectual disability and more frequently affects male individuals — anxiety, ...

AHS is often caused by brain injury or neurodegenerative illnesses, but there is not enough research to determine any consistent cause or why it occurs. “Alien hand is little investigated because it ...

China has approved its first-ever invasive brain-computer interface product, marking a key regulatory milestone in Chinese startups’ quest to challenge US rivals such as Elon Musk-backed Neuralink ...

"There's some moments in the movie where I'm laughing or I'm just so charmed by [Rocky], which is like it's actually my kids," Gosling says Jack Smart is the Movies Staff Writer at PEOPLE. With 10 ...

Down syndrome is caused by an additional copy of chromosome 21, but for decades, scientists have struggled to understand how this extra chromosome leads to intellectual disability. The new study, ...

In this detail of a figure from the paper, Rett syndrome endothelial cells (right) show less expression of ZO-1 (green), a key protein for forming a tight seal in blood vessels. Control cells (left) ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA. In rejecting RGX-121, the FDA raised concerns about its clinical ...